Shares of MiMedx are plunging after the U.S. Attorney’s Office of the District of South Carolina reported that a grand jury indicted three health care providers for the Department of Veterans Affairs on allegations that they “cultivated relationships with MiMedx sales representatives and other officials” and conspired to cause the “excessive use of MiMedx products on VA patients in South Carolina.” Shares of MiMedx are down 19%, or $1.54, to $6.47 after the indictment, dated May 8, was circulated
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.